File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

강주헌

Kang, Joo H.
Translational Multiscale Biofluidics Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Inhibition of mammary tumor growth using lysyl oxidase-targeting nanoparticles to modify extracellular matrix

Author(s)
Kanapathipillai, MathumaiMammoto, AkikoMammoto, TadanoriKang, Joo H.Jiang, ElisabethGhosh, KaustabhKorin, NetanelGibbs, AshleyMannix, RobertIngber, Donald E.
Issued Date
2012-05
DOI
10.1021/nl301206p
URI
https://scholarworks.unist.ac.kr/handle/201301/19506
Fulltext
http://pubs.acs.org/doi/abs/10.1021/nl301206p
Citation
NANO LETTERS, v.12, no.6, pp.3213 - 3217
Abstract
A cancer nanotherapeutic has been developed that targets the extracellular matrix (ECM)-modifying enzyme lysyl oxidase (LOX) and alters the ECM structure. Poly(D,L-lactide-co-glycolide) nanoparticles (similar to 220 nm) coated with a LOX inhibitory antibody bind to ECM and suppress mammary cancer cell growth and invasion in vitro as well as tumor expansion in vivo, with greater efficiency than soluble anti-LOX antibody. This nanomaterials approach opens a new path for treating cancer with higher efficacy and decreased side effects.
Publisher
AMER CHEMICAL SOC
ISSN
1530-6984

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.